LID.L Regulatory News (LID)

7 Jun 2007 07:00

For immediate release 7 June 2007 LiDCO Group Plc ('the Company') LiDCO announces exclusive critical care marketing collaboration with Becton Dickinson UK

LiDCO, the UK based, AIM-quoted cardiovascular monitoring company, today announces the signing of an exclusive UK marketing collaboration with Becton, Dickinson U.K. Limited. BD is a leading global medical technology company (see www.bd.com).

The collaboration provides that certain products currently sold by the BD Medical - Medical Surgical Systems unit for the critical care market will be jointly promoted in selected UK hospitals where LiDCO has existing sales and customer relationships. LiDCO's strong customer relationship with critical care units in UK hospitals was a key factor in BD's decision to collaborate. This marketing collaboration will result in enhanced sales coverage for BD's critical care product lines in the territory. Under the terms of the agreement, LiDCO will receive a fee based on sales in return for its promotional services.

The marketing collaboration will include the promotion by LiDCO of the following products: BD DTX Plus¢â€ž¢ Disposable Blood Transducers and BD Gabarith¢â€ž¢ Disposable Transducer Sets; BD¢â€ž¢ Reusable Pressure Transducers, Disposable Domes & Accessories ; BD Safedraw¢â€ž¢ "Closed Loop" Arterial Blood Sampling Sets;

BD Exacta¢â€ž¢ Percutaneous Sheath Introducer Sets; BD Criticath¢â€ž¢ Pulmonary Artery Catheters; BD Critikit¢â€ž¢ Injectate Systems; BD Careflow¢â€ž¢ Central Venous Catheters and BD Hydrocath Assure¢â€ž¢ Antimicrobial Coated Central Venous Catheters.

Dr Terry O'Brien, Chief Executive of LiDCO, commenting on the agreement stated: "This arrangement with a major corporation of the stature of BD reflects the regard with which our Company, products and UK sales team are held within the medical device industry. Together with BD, we will now be able to offer UK hospitals a broader portfolio of products for all critical care and anesthesia patients.

We share with BD the ambition to provide our acute care customers with the best possible products and services to improve outcomes and reduce complications such as infections. This collaboration significantly increases our UK market opportunity and competitiveness. There is a tremendous technological and marketing synergy between our two companies."

Mr Johnny Lundgren, BD Country General Manager, UK & Ireland, stated:

"BD designs and markets innovative products that address significant healthcare problems and deliver demonstrably higher benefits to patients, healthcare workers and researchers. Collaborating with LiDCO, an innovative company in an important healthcare market, will reinforce our capabilities to serve that market, in line with our corporate purpose of `Helping all people live healthy lives".

- ENDS -

For more information please contact:

LiDCO Group Plc Tel: +44 (0)20 7749 1500 Terry O'Brien - Chief Executive Buchanan Communications Tel: +44 (0)20 7466 5000 Tim Anderson, James Strong Notes for EditorsAbout LiDCO Group Plc

LiDCO is a UK-based AIM-traded developer, manufacturer and leading supplier of minimally invasive, computer-based hemodynamic monitoring equipment and disposables used primarily for the management of critical care and cardiovascular risk hospital patients. Use of LiDCO's technology has been shown to significantly reduce the complications (particularly infections) and costs associated with major surgery. The technology was invented in the Department of Applied Physiology based at St Thomas' Hospital, London. For more information please see www.lidco.com.

The Company's manufacturing facility is in Hoxton, London and its current products are:

* LiDCOplus and PulseCO monitors: computer-based platforms for displaying a range of real-time, continuous hemodynamic parameters including cardiac output, oxygen delivery and fluid volume;

* LiDCO disposables: used in conjunction with the LiDCOplus Monitor to accurately determine cardiac output in a minimally-invasive manner.

* LiDCOview - software product for use on a PC: designed to aide clinical audit, teaching and research activities.

* LiDCOlive - software product in development for the remote display of hemodynamic monitoring parameters derived through use of the LiDCOplus monitor.

Distribution Network:

The Company has now achieved registration of its products in 14 markets in Europe, the USA, Brazil, South Korea and Japan. It sells direct in the UK and USA, and elsewhere through a worldwide network of specialty critical care distributors.